The U.S. FDA said on Friday clinical trials testing COVID-19 vaccines for children are expected to include a monitoring period of at least two months to ensure safety.
Pfizer to submit COVID-19 vaccine approval for kids as young as 5 in coming weeks
The U.S. FDA said on Friday clinical trials testing COVID-19 vaccines for children are expected to include a monitoring period of at least two months to ensure safety.